Provigil News
Most Popular Provigil Story
Nexium, Actos, or Diovan? Analysts try to ID Ranbaxy's 3 sacrifices
Now that the dust has settled around Ranbaxy Laboratories' deal with the U.S. Justice Department, three missing bits of information are looming large. Which three first-to-file exclusivity rights Read more...
Latest Headlines
- December 7, 2011
- October 24, 2011
- October 10, 2011
- October 3, 2011
- April 29, 2011
- December 23, 2010
- July 23, 2010
- July 23, 2010
- July 15, 2010
- June 10, 2010
- March 30, 2010
- December 22, 2009
- August 7, 2009
- March 18, 2009
- December 8, 2008
- November 18, 2008
- April 10, 2008
- March 26, 2008
- February 20, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
